VIR BIOTECHNOLOGY INC (VIR) Institutional Ownership and Insiders Activity
VIR BIOTECHNOLOGY INC (VIR) is widely held by institutional investors, with 248 firms reporting positions valued at approximately $1.50B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $210.71M in VIR holdings in its latest filing.
Recent insider activity includes 3 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
248
Total Reported Value
$1.50B
Largest Holder
Blackrock, Inc.
Largest Position
$210.71M
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
33
Funds Exiting Positions
49
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$210.71M
- Arch Venture Management, Llc$129.35M
- Vanguard Portfolio Management Llc$117.14M
- Sb Investment Advisers (Uk) Ltd$111.56M
- State Street Corp$101.53M
VIR News
All news- Arch Venture Management LLC: Significant Investment Increase in BOLD During Q2 2026
Aug 19, 2026 · valut.ai
Related VIR Institutional Insights:
- VIR 13F Institutional Holders
- VIR Superinvestors
- VIR Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- VIR Insider Trading & SEC Form 4 Activity
- VIR Articles
- Top Institutional Investor Stock Rankings